Vicarious Surgical (RBOTW) EPS (Weighted Average and Diluted) (2021 - 2025)
Vicarious Surgical (RBOTW) reported EPS (Weighted Average and Diluted) of -$1.86 for Q3 2025, up 35.86% year-over-year from -$1.37 in Q3 2024, and up 16.59% quarter-over-quarter from -$2.23 in Q2 2025.
Vicarious Surgical (RBOTW) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 5 years of EPS (Weighted Average and Diluted) data on file, last reported at -$1.86 in Q3 2025.
- EPS (Weighted Average and Diluted) for Q3 2025 came in at -$1.86, up 35.86% year-over-year; the trailing twelve-month figure through Sep 2025 was -$9.04 (up 11.55% YoY), and the FY2024 annual result was -$10.74, up 26.44% from the prior year.
- EPS (Weighted Average and Diluted) advanced to -$1.86 in Q3 2025 per RBOTW's latest filing, from -$2.23 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.33 in Q1 2022 and troughed at -$3.04 in Q3 2023.
- A 5-year average of -$1.36 and a median of -$1.83 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) jumped 650.0% in 2022, then slumped 2058.33% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.49 in 2021, then soared by 59.18% to -$0.2 in 2022, then tumbled by 815.0% to -$1.83 in 2023, then fell by 28.42% to -$2.35 in 2024, then gained by 20.85% to -$1.86 in 2025.
- Business Quant data shows RBOTW's EPS (Weighted Average and Diluted) at -$1.86 in Q3 2025, -$2.23 in Q2 2025, and -$2.6 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.86 |
| Jun 30, 2025 | -2.23 |
| Mar 31, 2025 | -2.60 |
| Dec 31, 2024 | -2.35 |
| Sep 30, 2024 | -2.90 |
| Jun 30, 2024 | -2.59 |
| Mar 31, 2024 | -2.90 |
| Dec 31, 2023 | -1.83 |
| Sep 30, 2023 | -3.04 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | -0.21 |
| Sep 30, 2022 | -0.20 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | 0.33 |
| Sep 30, 2021 | -0.49 |
| Jun 30, 2021 | -0.08 |
| Mar 31, 2021 | -0.06 |